WBAI [500.com] 6-K:
[]
CHNR [CHINA NATURAL RESOURCES] 20-F/A:
[] [CERTIFICATION I, Wong Wah On Edward, certify that: 1. I have reviewed this Amendment No. 1 to the annual report on Form 20-F of China Natural Resources, Inc.; and 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necess]
CHL [CHINA MOBILE] 6-K: (Original Filing)
[Number 1.1 Announcement with respect to Grant of Share Options Under the Share Option Scheme, dated June 12, 2020 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network]
CHL [CHINA MOBILE] 6-K: Number 1.1 Announcement with respect to Grant of
[Number 1.1 Announcement with respect to Grant of Share Options Under the Share Option Scheme, dated June 12, 2020 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network]
CCCL [China Ceramics] EFFECT: (Original Filing)
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .For]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19 Beijing-June 13, 2020 — Sinovac Biotech Ltd. (“Sinovac” or the “ Company”)(Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced positive]
CCCL [China Ceramics] EFFECT: .FormData {color: blue; background-color: white; font-size: small; font-family:
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .For]
SVA [SINOVAC BIOTECH] 6-K: Sinovac Announces Positive Preliminary Results of Phase I/II
[Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19 Beijing-June 13, 2020 — Sinovac Biotech Ltd. (“Sinovac” or the “ Company”)(Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced positive]
